Effects of amperozide and tiospirone, atypical antipsychotic 5-HT2 drugs, on food-reinforced behavior in rats

被引:9
作者
Arolfo, MP
McMillen, BA [1 ]
机构
[1] E Carolina Univ, Sch Med, Dept Pharmacol, Greenville, NC 27858 USA
[2] E Carolina Univ, Sch Med, Ctr Alcohol & Drug Abuse Studies, Greenville, NC 27858 USA
关键词
amperozide; tiospirone; food reward; antipsychotic drugs; 5-HT2; receptors;
D O I
10.1016/S0031-9384(99)00141-9
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Amperozide (AMPZ) is a 5-HT2 receptor antagonist that can decrease consumption of ethanol and prevent cocaine conditioning of a place preference. Tiospirone (TSP) is a 5-HT2 receptor antagonist with affinity for D-2, 5-HT1a, and 5-HT7, and sigma receptors, which can decrease consumption of ethanol while increasing food intake. Both drugs were tested for inhibition of food reinforced bar-pressing behavior. Fasted Sprague-Dawley male rats were trained daily on a 15-min FR-5 schedule. After response rates stabilized, each rat in one group received a 60-min pretreatment s.c. with saline, 0.25, 0.75, or 2.5 mu mol/kg of AMPZ (injections were twice per week and counterbalanced). Each rat in a second group received a 60-min pretreatment with saline, 0.1, 0.3, or 1.0 mu mol/kg of TSP. The dose of 2.5 mu mol/kg of AMPZ reduced the number of food reinforcements by 21% from saline. The effect was due to a greater decline in bar pressing during the last 5-min block. TSP, 0.3 and 1.0 mu mol/kg, significantly reduced the number of reinforcements by 45 and 94% from saline, respectively. In a study of catalepsy, TSP at 0.3 and 1.0 mu mol/kg produced akinesia and catalepsy, respectively. Our results indicate that AMPZ-induced reduction of alcohol intake is not due to a nonspecific effect on reward, but the akinetic effects of TSP masks whether or not it has effects on reward. (C) 1999 Elseiver Science Inc. All rights reserved.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 31 条
[1]   Food reward: Brain substrates of wanting and liking [J].
Berridge, KC .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1996, 20 (01) :1-25
[2]  
BJORK A, 1992, NOVEL ANTIPSYCHOTIC DRUGS, P47
[3]  
BLUNDELL JE, 1977, INT J OBESITY, V1, P15
[4]  
BORISON RL, 1989, PSYCHOPHARMACOL BULL, V25, P190
[5]  
CHRISTENSSON EG, 1985, ACTA PHYSIOL SCAND, V124, P281
[6]   COMPARISON OF ABILITIES OF TYPICAL NEUROLEPTIC AGENTS AND OF THIORIDAZINE, CLOZAPINE, SULPIRIDE AND METOCLOPRAMIDE TO ANTAGONIZE HYPERACTIVITY INDUCED BY DOPAMINE APPLIED INTRACEREBRALLY TO AREAS OF EXTRAPYRAMIDAL AND MESOLIMBIC SYSTEMS [J].
COSTALL, B ;
NAYLOR, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 40 (01) :9-19
[7]  
DOURISH CT, 1992, ADV BIOSCI, V85, P179
[8]  
DOURISH CT, 1995, OBES RES, V3, P449
[9]   AMPEROZIDE AND CONDITIONED BEHAVIOR IN RATS - POTENTIATION BY CLASSICAL NEUROLEPTICS AND ALPHA-METHYLPARATYROSINE [J].
EGBE, P ;
ENGEL, J ;
GUSTAFSSON, B ;
CHRISTENSSON, E .
PHARMACOLOGY & TOXICOLOGY, 1990, 66 :18-21
[10]   EFFECTS OF AMPEROZIDE IN 2 ANIMAL-MODELS OF ANXIETY [J].
ENGEL, JA ;
EGBE, P ;
LILJEQUIST, S ;
SODERPALM, B .
PHARMACOLOGY & TOXICOLOGY, 1989, 64 (05) :429-433